相关实验视频

Updated: Sep 18, 2025

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

作为针对性瘤治疗的YTHDF1抑制剂的Pyrrolidinium富勒烯

Xin Wang^1,2, Weixin Zhang^1,3, Jiawei Huo¹

¹Beijing National Laboratory for Molecular Sciences, Key Laboratory of Molecular Nanostructure and Nanotechnology, Institute of Chemistry, Chinese Academy of Science, Beijing, 100190, P. R. China.

Advanced healthcare materials

|June 23, 2025

概括

罗利丁富勒伦显示出作为新型癌症治疗药物的前景. 这些化合物抑制YTHDF1 (YTH N6 - 甲基氨酸RNA结合蛋白1),抑制瘤生长和扩散,毒性最小.

科学领域:

药用化学医学化学
在瘤学瘤学.
纳米技术纳米技术

背景情况:

癌症需要创新的向疗法.
YTH N6 - 甲基氨酸RNA结合蛋白1 (YTHDF1) 是癌症中潜在的治疗点.

研究的目的:

为了研究pyrrolidinium fullerenes作为YTHDF1抑制剂用于癌症治疗.
为了合成和描述新型的pyrrolidinium富勒烯衍生物.

主要方法:

功能化罗利丁富勒烯 (NDMPFI,NMBPFI,NMHPFI) 的合成和表征.
表面等离子体共振 (SPR) 和分子动力学 (MD) 模拟用于结合亲和度评估.
关于癌细胞增殖,细胞周期,EMT和YTHDF1降解的体外机制研究.
在肺癌模型中进行体内瘤抑制研究.

主要成果:

合成的pyrrolidinium富勒烯显示出强大的YTHDF1结合亲和力.
通过诱导G0/G1的逮捕和降低Cyclin D1,CDK4和c-Myc的调节,NDMPFI抑制了癌细胞的增殖.
NDMPFI抑制了表皮-介质酶过渡 (EMT) 并促进了YTHDF1的蛋白质体降解.
在体内研究显示,在没有全身毒性的肺癌模型中显著抑制瘤.

结论:

罗利丁富勒伦,特别是NDMPFI,是具有抗癌潜力的有效YTHDF1抑制剂.
这些化合物通过调节YTHDF1表达和下游途径,为向癌症治疗提供了一种新的策略.
需要进一步开发作为抗癌物质的pyrrolidinium fullerenes.

关键词:

癌症治疗疗法癌症治疗细胞循环停止细胞循环停止烯 (pyrrolidinium) 富勒是一种烯 (pyrrolidinium fullerenes) 的一种化合物.这是一种ythdf1抑制剂.

更多相关视频

Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment

Automated Preparation of [⁶⁸Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment

Published on: April 25, 2025

Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers

Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers

Published on: October 28, 2015

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Drugs that Stabilize Microtubules

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...